McKesson Corporation (MCK) is a publicly traded Healthcare sector company. As of September 10, 2026, MCK trades at $892.24 with a market cap of $103.66B and a P/E ratio of 23.88. MCK moved +0.29% today. Year to date, MCK is +8.70%; over the trailing twelve months it is +26.38%. Its 52-week range spans $570.51 to $999.00. Analyst consensus is strong buy with an average price target of $987.75. Rallies surfaces MCK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MCK news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $892.24 |
| Market Cap | $103.66B |
| P/E Ratio | 23.88 |
| EPS | $37.47 |
| Dividend Yield | 0.94% |
| 52-Week High | $999.00 |
| 52-Week Low | $570.51 |
| Volume | 539.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $410.98B |
| Net Income | $5.30B |
| Gross Margin | 3.64% |
13 analysts cover MCK: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $987.75.